Myocardial Infarction (MI) Therapeutics Market size is estimated to grow by $2024.94 million from 2022 to 2026 at a CAGR of 5% with the antithrombotics having largest market share. Rising incidence of MI will be a key driver fueling the myocardial infarction (mi) therapeutics growth during the forecast period.